[Dependence receptors DCC and UNC5H: the role of apoptosis in the control of tumorigenesis].
Recent studies have led a different view about membrane receptors. While a receptor used to be considered as inactive until bound by its ligand, it has been proposed that some receptors may also be active in the absence of their ligand. These so-called dependence receptors induce a specific death signal when the ligand is absent from the cell. Therefore, the expression of one of these receptors drives the cell to become dependent on the presence of the ligand for its survival. We have hypothesized that this mechanism allows inhibition of tumor growth, by inducing apoptosis of "abnormal" cells that would usually grow when ligand are unavailable--i.e., during local growth of tumor cells or growth beyond primary tumor site -. Along this line, back in the early 90s, Vogelstein and colleagues suggested that a gene called DCC (for "deleted in colorectal cancer") could be a tumor suppressor gene because it was found to be deleted in more than 70 % of colorectal cancers, as well as in many other cancers. During the last fifteen years, controversial data have failed to firmly establish whether DCC is indeed a tumor suppressor gene. However, our observation that DCC behaves as a dependence receptor that induces cell death unless its ligand netrin-1 is present, together with the fact that mice engineered to block DCC-induced cell death by overexpressing netrin-1 are predisposed to develop colorectal tumors, strengthen the role of dependence receptors as tumor suppressors. In this review, we will describe the implication of the netrin-1/receptor pairs as novel negative regulators of tumor development.
Centre Léon Bérard, Apoptose, Cancer et Développement, Laboratoire labellisé, La Ligue, CNRS FRE2870, 69008 Lyon. mehlen@lyon.fnclcc.fr
Patrick
P
Mehlen
David
D
Goldschneider
D000818:Animals; D017209:Apoptosis / Q000502:physiology*; D002471:Cell Transformation, Neoplastic / Q000473:pathology*; D015179:Colorectal Neoplasms / Q000235:genetics; D000075389:DCC Receptor; D017353:Gene Deletion; D016163:Genes, DCC; D006801:Humans; D007413:Intestinal Mucosa / Q000166:cytology; D008024:Ligands; D051379:Mice; D018345:Mice, Knockout; D009414:Nerve Growth Factors / Q000502:physiology; D000075386:Netrin Receptors; D000075388:Netrin-1; D017434:Protein Structure, Tertiary; D011956:Receptors, Cell Surface / Q000737:chemistry / Q000145:classification / Q000172:deficiency / Q000235:genetics / Q000502:physiology*; D025521:Tumor Suppressor Proteins / Q000737:chemistry / Q000145:classification / Q000172:deficiency / Q000235:genetics / Q000502:physiology*
D000075389:DCC Receptor; C501909:DCC protein, human; C501910:Dcc protein, mouse; D008024:Ligands; C000617351:NTN1 protein, human; D009414:Nerve Growth Factors; D000075386:Netrin Receptors; C000617353:Ntn1 protein, mouse; D011956:Receptors, Cell Surface; D025521:Tumor Suppressor Proteins; C105653:Unc5c protein, mouse; D000075388:Netrin-1